Search
Descriptor in English: Fenoldopam
Descriptor in Spanish: Fenoldopam
Descriptor in Portuguese: Fenoldopam
Descriptor in French: Fénoldopam
Entry term(s): Corlopam
Fenoldopam Hydrobromide
Fenoldopam Mesylate
Hydrobromide, Fenoldopam
SK&F 82526
SK&F 82526J
SK&F-82526
SK&F-82526J
SK&F82526
SK&F82526J
SKF 82526
SKF 82526J
SKF-82526
SKF-82526J
SKF82526
SKF82526J
Tree number(s): D03.633.100.079.300
Scope note: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Online Note: use FENOLDOPAM (NM) to search FENOLDOPAM 1982-94
History Note: 95; was FENOLDOPAM (NM) 1982-94
DeCS UI: 32253
Descriptor UI: D018818
Date Established: 1995/01/01
Date of Entry: 1994/06/01
Revision Date: 2016/05/31
Fenoldopam - Preferred
Concept UI M0028173
Scope note A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Preferred term Fenoldopam
Fenoldopam Hydrobromide - Narrower
Concept UI M0329177
Preferred term Fenoldopam Hydrobromide
Entry term(s) Hydrobromide, Fenoldopam
SK&F-82526 - Narrower
Concept UI M0353541
Preferred term SK&F-82526
Entry term(s) SK&F 82526
SK&F82526
SKF 82526
SKF-82526
SKF82526
SKF-82526J - Narrower
Concept UI M0028174
Preferred term SKF-82526J
Entry term(s) SK&F 82526J
SK&F-82526J
SK&F82526J
SKF 82526J
SKF82526J
Corlopam - Narrower
Concept UI M0028175
Preferred term Corlopam
Fenoldopam Mesylate - Narrower
Concept UI M0329176
Preferred term Fenoldopam Mesylate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey